公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2020 | Factors Affecting Usage Levels and Trends of Innovative Oncology Drugs Upon and After Reimbursement Under Taiwan National Health Insurance: Interrupted Time Series Analysis | Liao K.-H.; BOR-SHENG KO ; Chen L.-K.; FEI-YUAN HSIAO | Clinical and Translational Science | 2 | 2 | |
2010 | Focal Adhesion Kinase as a Therapeutic Target of Bortezomib | BOR-SHENG KO ; Chang T.-C.; Liou J.-Y. | Anti-Cancer Agents in Medicinal Chemistry | 6 | 6 | |
2020 | Frontline treatments in extremely elderly patients with diffuse large B-cell lymphoma: A population-based study in Taiwan, 2010-2015 | HUAI-HSUAN HUANG ; BOR-SHENG KO ; Chen H.-M.; Chen L.-J.; Wang C.-Y.; Hsiao F.-Y.; FEI-YUAN HSIAO | Immunity and Ageing | 5 | 5 | |
2005 | Gastrointestinal: Burkitt's lymphoma | JYH-MING LIOU ; HSIU-PO WANG ; BOR-SHENG KO ; TSU-YAO CHENG ; MING-SHIANG WU ; Lin J.-T. | Journal of Gastroenterology and Hepatology (Australia) | 7 | 8 | |
2015 | GATA2 mutations in patients with acute myeloid leukemia-paired samples analyses show that the mutation is unstable during disease evolution | HSIN-AN HOU ; YUN-CHU LIN ; Kuo Y.-Y.; WEN-CHIEN CHOU ; CHIEN-CHIN LIN ; Liu C.-Y.; Chen, Chien-Yuan ; LIANG-IN LIN ; Tseng M.-H.; Huang C.-F.; Chiang Y.-C.; Liu M.-C.; Liu C.-W.; JIH-LUH TANG ; MING YAO ; SHANG-YI HUANG ; BOR-SHENG KO ; SZU-CHUN HSU ; SHANG-JU WU ; WOEI TSAY ; YAO-CHANG CHEN ; HWEI-FANG TIEN | Annals of Hematology | 21 | 20 | |
2018 | GATA2 zinc finger 1 mutations are associated with distinct clinico-biological features and outcomes different from GATA2 zinc finger 2 mutations in adult acute myeloid leukemia | FENG-MING TIEN ; HSIN-AN HOU ; CHENG-HONG TSAI ; JIH-LUH TANG ; Chiu, Yu-Chiao; Chen, Chien-Yuan ; Kuo, Yuan-Yeh; Tseng, Mei-Hsuan; Peng, Yen-Ling; Liu, Ming-Chih; Liu, Chia-Wen; Liao, Xiu-Wen; LIANG-IN LIN ; Lin, Chien-Ting; SHANG-JU WU ; BOR-SHENG KO ; SZU-CHUN HSU ; SHANG-YI HUANG ; MING YAO ; WEN-CHIEN CHOU ; HWEI-FANG TIEN | Blood Cancer Journal | 29 | | |
2016 | Genetic alterations and their clinical implications in older patients with acute myeloid leukemia | CHENG-HONG TSAI ; HSIN-AN HOU ; JIH-LUH TANG ; Liu, C.-Y.; CHIEN-CHIN LIN ; WEN-CHIEN CHOU ; Tseng, M.-H.; Chiang, Y.-C.; Kuo, Y.-Y.; Liu, M.-C.; Liu, C.-W.; LIANG-IN LIN ; WOEI TSAY ; MING YAO ; Li, C.-C.; SHANG-YI HUANG ; BOR-SHENG KO ; SZU-CHUN HSU ; Chen, Chien-Yuan ; Lin, C.-T.; SHANG-JU WU ; HWEI-FANG TIEN | Leukemia | 101 | 90 | |
2014 | Guidelines for treating iron overload in myelodysplastic syndromes: A Taiwan consensus statement | BOR-SHENG KO ; Chang C.-S.; Chang M.-C.; Chen T.Y.; Chiou T.-J.; Chiu C.-F.; Huang W.-L.; Kao W.-Y.; Lan Y.-J.; Lin S.-F.; Tan T.-D.; JIH-LUH TANG ; Tzeng C.-H.; Wang P.-N.; Yet S.-P.; HWEI-FANG TIEN | International Journal of Hematology | 8 | 6 | |
2022 | Hepatitis B surface antigen positivity is associated with progression of disease within 24 months in follicular lymphoma | Chieh-Lung Cheng ; Fang, Wei-Quan; YU-JEN LIN ; CHANG-TSU YUAN ; BOR-SHENG KO ; JIH-LUH TANG ; HWEI-FANG TIEN | Journal of cancer research and clinical oncology | 4 | 3 | |
2011 | High bone marrow angiopoietin-1 expression is an independent poor prognostic factor for survival in patients with myelodysplastic syndromes | Chieh-Lung Cheng ; HSIN-AN HOU ; Jhuang J.-Y.; CHUNG-WU LIN ; Chen, Chien-Yuan ; JIH-LUH TANG ; WEN-CHIEN CHOU ; Tseng M.-H.; MING YAO ; SHANG-YI HUANG ; BOR-SHENG KO ; SZU-CHUN HSU ; SHANG-JU WU ; WOEI TSAY ; YAO-CHANG CHEN ; HWEI-FANG TIEN | British journal of cancer | 23 | 22 | |
2015 | High incidences of invasive fungal infections in acute myeloid leukemia patients receiving induction chemotherapy without systemic antifungal prophylaxis: A prospective observational study in Taiwan | JIH-LUH TANG ; HSIANG-CHI KUNG ; Lei W.-C.; MING YAO ; UN-IN WU ; SZU-CHUN HSU ; Lin C.-T.; Li C.-C.; SHANG-JU WU ; HSIN-AN HOU ; WEN-CHIEN CHOU ; SHANG-YI HUANG ; WOEI TSAY ; YAO-CHANG CHEN ; YEE-CHUN CHEN ; SHAN-CHWEN CHANG ; BOR-SHENG KO ; HWEI-FANG TIEN | PLoS ONE | 48 | 42 | |
2021 | High rate of invasive fungal infections after non-T cell depleted haploidentical allo-HSCT even under antifungal prophylaxis | Lien M.-Y.; Yeh S.-P.; Gau J.-P.; Wang P.-N.; Li S.-S.; Dai M.-S.; Chen T.C.; Hsieh P.-Y.; Chiou L.-W.; Huang W.-H.; Liu Y.-C.; BOR-SHENG KO ; Taiwan Blood; Marrow Transplantation Registry (TBMTR) | Bone Marrow Transplantation | 4 | 3 | |
2013 | Higher bone marrow LGALS3 expression is an independent unfavorable prognostic factor for overall survival in patients with acute myeloid leukemia | Chieh-Lung Cheng ; HSIN-AN HOU ; Lee, Ming-Cheng; Liu, Chieh-Yu; Jhuang, Jie-Yang; Lai, Yan-Jun; CHUNG-WU LIN ; Chen, Huan-Yuan; Liu, Fu-Tong; WEN-CHIEN CHOU ; Chen, Chien-Yuan ; JIH-LUH TANG ; MING YAO ; SHANG-YI HUANG ; BOR-SHENG KO ; SHANG-JU WU ; WOEI TSAY ; HWEI-FANG TIEN | Blood | 50 | 38 | |
2015 | Higher decorin levels in bone marrow plasma are associated with superior treatment response to novel agent-based induction in patients with newly diagnosed myeloma - A retrospective study | SHANG-YI HUANG ; Lin H.-H.; MING YAO ; JIH-LUH TANG ; SHANG-JU WU ; HSIN-AN HOU ; WEN-CHIEN CHOU ; SHENG-CHIEH CHOU ; SZU-CHUN HSU ; BOR-SHENG KO ; Lu H.-Y.; WOEI TSAY ; HWEI-FANG TIEN | PLoS ONE | 10 | 9 | |
2005 | Highly efficient cellular labeling of mesoporous nanoparticles in human mesenchymal stem cells: implication for stem cell tracking | Huang, Dong-Ming; Hung, Yann; BOR-SHENG KO ; SZU-CHUN HSU ; Chen, Wei-Hsuan; CHUNG-LIANG CHIEN ; Tsai, Chih-Pin; Kuo, Chieh-Ti; Kang, Ju-Chiun; Yang, Chung-Shi; Mou, Chung-Yuan; YAO-CHANG CHEN | FASEB journal : official publication of the Federation of American Societies for Experimental Biology | 289 | 272 | |
2009 | HLA-DR-matched parental donors for allogeneic hematopoietic stem cell transplantation in patients with high-risk acute leukemia | SHANG-JU WU ; MING YAO ; JIH-LUH TANG ; BOR-SHENG KO ; HWEI-FANG TIEN ; YAO-CHANG CHEN | Journal of the Formosan Medical Association | 2 | 2 | |
2010 | Homologous RBC-derived vesicles as ultrasmall carriers of iron oxide for magnetic resonance imaging of stem cells. | Chang M.; Hsiao J.K.; MING YAO ; Chien L.Y.; SZU-CHUN HSU ; BOR-SHENG KO ; Chen S.T.; HON-MAN LIU ; YAO-CHANG CHEN ; Yang C.S.; Huang D.M. | Nanotechnology | 29 | 27 | |
2018 | Hyperleukocytosis is associated with distinct genetic alterations and is an independent poor-risk factor in de novo acute myeloid leukemia patients | FENG-MING TIEN ; HSIN-AN HOU ; CHENG-HONG TSAI ; JIH-LUH TANG ; Chen, Chien-Yuan ; Kuo, Yuan-Yeh; Li, Chi-Cheng; Lin, Chien-Ting; MING YAO ; SHANG-YI HUANG ; BOR-SHENG KO ; SZU-CHUN HSU ; SHANG-JU WU ; WOEI TSAY ; Tseng, Mei-Hsuan; Liu, Ming-Chih; Liu, Chia-Wen; LIANG-IN LIN ; WEN-CHIEN CHOU ; HWEI-FANG TIEN | European Journal of Haematology | 29 | 23 | |
2023 | Ibrutinib for First-Line Treatment of Chronic Graft-Versus-Host Disease: Results From the Randomized Phase III iNTEGRATE Study | Miklos, David Bernard; Abu Zaid, Mohammad; Cooney, Julian P; Albring, Jörn C; Flowers, Mary; Skarbnik, Alan P; Yakoub-Agha, Ibrahim; BOR-SHENG KO ; Bruno, Benedetto; Waller, Edmund K; Yared, Jean; Sohn, Sang Kyun; Bulabois, Claude-Eric; Teshima, Takanori; Jacobsohn, David; Greinix, Hildegard; Mokatrin, Ahmad; Lee, Yihua; Wahlstrom, Justin T; Styles, Lori; Socie, Gerard | Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 13 | 4 | |
2014 | IDH mutations are closely associated with mutations of DNMT3A, ASXL1 and SRSF2 in patients with myelodysplastic syndromes and are stable during disease evolution | CHIEN-CHIN LIN ; HSIN-AN HOU ; WEN-CHIEN CHOU ; Kuo Y.-Y.; Liu C.-Y.; Chen, Chien-Yuan ; Lai Y.-J.; Tseng M.-H.; Huang C.-F.; Chiang Y.-C.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; JIH-LUH TANG ; MING YAO ; SHANG-YI HUANG ; BOR-SHENG KO ; SHANG-JU WU ; WOEI TSAY ; YAO-CHANG CHEN ; HWEI-FANG TIEN | American Journal of Hematology | 75 | 69 | |